To lead the integration and growth of the SPECT business, SHINE has named Michael Rossi as CEO of SHINE SPECT USA, LLC.

About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...

Reston, Va. (May 3, 2012) – The use of single positron emission computed tomography (SPECT)/computed tomography (CT) has been reported to change clinical management in a significant number of thyroid ...

June 22, 2004 (Philadelphia) — A relatively new imaging technique using combined single-photon emission computed tomography (SPECT) and low-dose computed tomography (CT) may significantly improve the ...

Many people have experienced a scan in the nuclear medicine department of a hospital or clinic. It may seem a straightforward procedure for the patient, but the technology involved is a complex ...

Siemens Healthineers received clearance from the FDA for its latest scanner that combines SPECT and CT imaging into a comparatively smaller package. The Symbia Pro.specta is designed to replace ...

Reston, Va.—In a study to determine the diagnostic value of molecular imaging in nodal staging of patients with thyroid cancer, researchers were able for the first time to accurately distinguish ...

When it comes to identifying primary hyperparathyroidism (pHPT), choline positron emission tomography and computed tomography (PET-CT) may be the way to go. In a meta-analysis of 119 comparative ...

U-SPECT 7 CT from MILabs (a Rigaku company) offers unmatched preclinical dynamic and whole-body Single Photon Emission Computed Tomography (SPECT) performance, integrated with diagnostic micro-CT.